Mike Hale

Statistics

Publications

Citations

705

H-Index

Active since

1999

Affiliations

GlaxoSmithKline (United States)(Current)

Mike Hale is an author at GlaxoSmithKline (United States) specializing in mycophenolate-based immunosuppression, transplant pharmacology, and renal pharmacokinetics.

Publications per year

1999–2002

Publications

A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1

Teun van Gelder, Luuk B. Hilbrands, Yves Vanrenterghem et al. · Transplantation · 1999 · 540 citations

Medicine, Pharmacokinetics, Pharmacology +17

Limited Sampling Strategy for the Estimation of Mycophenolic Acid Area under the Curve in Adult Renal Transplant Patients Treated with Concomitant Tacrolimus

T. Pawiński, Mike Hale, Magda Korecka et al. · Clinical Chemistry · 2002 · 165 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–2 of 2